Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Partly Blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group

NCT07405853 is registered in ClinicalTrials.gov with Gedea Biotech AB as lead sponsor.

NCT NCT07405853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07405853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Partly Blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group
Lead sponsor
Gedea Biotech AB
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 3, 2026
Completion date
October 31, 2026
Enrollment
48 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal candidiasis (vvc)